Australian Scientists Unveil Breakthrough Blood Test for Endometriosis

A pioneering test designed to diagnose endometriosis, a debilitating condition affecting one in nine Australian women, has been developed by researchers at the Royal Women’s Hospital and the University of Melbourne. The breakthrough, detailed in the esteemed journal Human Reproduction, represents a crucial step towards providing women with an accurate, non-invasive method to detect early stages of the disease.

Understanding Endometriosis

Endometriosis, a widespread chronic disease affecting around 190 million women and teenage girls globally, occurs when tissue similar to the lining of the uterus grows outside its intended location, causing severe pelvic pain, painful periods, and often infertility. Currently, diagnosis is a long and arduous process—taking an average of seven years—and typically involves invasive procedures such as laparoscopies.

Key Statistics: The Urgency of Endometriosis

• Endometriosis affects one in nine women and girls in Australia.
• The diagnosis process averages seven years.
• The incidence is three times higher in women seeking fertility treatment.
• A reliable, non-invasive diagnostic test does not currently exist.

The Breakthrough Test

The novel blood test, known as PromarkerEndo, has been developed by Proteomics International in collaboration with the research institutions. The team analyzed plasma samples from over 800 participants across two independent groups to identify 10 protein biomarkers or ‘fingerprints’ in the blood of individuals with endometriosis.

“We identified 10 protein biomarkers, or ‘fingerprints’ in the blood, that can be found using our test, in women and girls with endometriosis.”

“The blood test, called PromarkerEndo, could significantly reduce the cost and time typically spent on diagnosing the cause of symptoms women and girls suffer from, often from the onset of menstruation.”

“A blood test is more cost-effective for patients and the health system than current diagnostic methods like ultrasounds, invasive laparoscopies, MRI’s and biopsies.”

—Dr Richard Lipscombe, Managing Director, Proteomics International Laboratories Ltd

The PromarkerEndo test demonstrates excellent accuracy in distinguishing between healthy individuals and those with early stages of endometriosis. This accuracy could revolutionize not only the cost-efficiency but also accessibility and promptness of diagnosis for millions of women.

Implications and Future Directions

Professor Peter Rogers, Research Director at the Royal Women’s Hospital and Professor of Women’s Health Research at the University of Melbourne, expressed his excitement about the potential impact of the discovery. “This breakthrough can significantly solve the critical need for a non-invasive, accurate test that can diagnose endometriosis at its early stages and address more advanced cases,” Rogers noted.

The research also highlights a higher incidence of endometriosis among women undergoing fertility treatments, underscoring the importance of early detection.

While there is no known cure for endometriosis, early diagnosis can greatly enhance treatment options and improve patient outcomes. “Detecting endometriosis early increases treatment options and may improve a patient’s response to laser ablation or existing medical therapies,” Professor Rogers stressed.

Economic Impact

The financial burden of endometriosis on the Australian healthcare system is substantial, estimated at $9.7 billion annually. The potential economic savings from an earlier diagnosis tool like PromarkerEndo could be immense.

A Call to Action

This new blood test marks a significant leap forward in women’s healthcare, offering hope to millions experiencing the debilitating symptoms of endometriosis. As research progresses, we look forward to more reliable and accessible diagnostic tools that will eventually become standard of care. For women and advocates working towards better endometriosis diagnosis and management, this test is a beacon of progress.

We invite you to comment on your thoughts about this groundbreaking research and share your experiences. Join the conversation by commenting below, subscribe to our newsletter to receive updates on future healthcare innovations, and share this article on your social media to help spread the word about this vital discovery.